Clinical Trials Directory

Trials / Suspended

SuspendedNCT06800053

FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Charles Kamen · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

Our aim for this study is to assess the feasibility and acceptability and explore potential outcomes of the adapted FOCUS On Us intervention in a two-arm pilot trial. The investigators will randomize 80 sexual and/or gender minority (SGM; e.g., lesbian, gay, bisexual, transgender, queer, etc.) cancer patients and their ≥80 informal caregivers (total N≥160) to either FOCUS On Us (adapted from the evidence-based FOCUS program) or a waitlist control.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFOCUS ON USThis intervention will include 5 sessions cover 5 core content areas, represented by the acronym FOCUS. Family involvement (F) Outlook and meaning (O) Coping effectiveness (C) Uncertainty reduction (U) Symptom management (S) Content from every area is presented in the 3 longer in-depth sessions and reinforced in the 2 shorter check-in sessions. FOCUS encourages participants to work as a team, communicate openly, and support one another, and uses skill building (e.g., stress reduction techniques, healthy behaviors), education (e.g., symptom trajectories, information gathering), and problem-solving therapy to address "here-and-now" issues that impact QOL. The intervention is flexible, allowing more attention to be spent on issues relevant to particular patients/caregivers.

Timeline

Start date
2026-04-01
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2025-01-29
Last updated
2025-05-07

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06800053. Inclusion in this directory is not an endorsement.